Asset Details

MbrlCatalogueTitleDetail

Do you wish to reserve the book?

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

by Makkar, Raj R , Giustino, Gennaro , Zazula, Ana , van Amsterdam, Ronald G.M , Søndergaard, Lars , Moreno, Raúl , Gullestad, Lars , Wildgoose, Peter , Vranckx, Pascal , Dangas, George D , Tchétché, Didier , Möllmann, Helge , Guimarães, Ana H.C , Kini, Annapoorna , Mack, Michael , Windecker, Stephan , Welsh, Robert C , Thomitzek, Karen , Volkl, Albert A , De Backer, Ole , Baldus, Stephan , von Lewinski, Dirk , Seeger, Julia , Tijssen, Jan G.P , Schäfer, Ulrich , Gilard, Martine , Wöhrle, Jochen , Herrmann, Howard C , Valgimigli, Marco , Mehran, Roxana

in 9NDF7JZ4M3 (Rivaroxaban) / A74586SNO7 (Clopidogrel) / Aged / Aged, 80 and over / Anticoagulants / Aspirin / Aspirin - adverse effects / Aspirin - therapeutic use / Aspirin/adverse effects/therapeutic use / Atrial Fibrillation - drug therapy / Bleeding / Cardiac arrhythmia / Cardiovascular & respiratory systems / Cardiovascular Diseases - mortality / Clopidogrel / Clopidogrel - adverse effects / Clopidogrel - therapeutic use / Clopidogrel/adverse effects/therapeutic use / Confidence intervals / Death / Drug Therapy, Combination / Embolisms / Factor Xa Inhibitors / Factor Xa Inhibitors - adverse effects / Factor Xa Inhibitors - therapeutic use / Factor Xa Inhibitors/adverse effects/therapeutic use / Female / Heart Valve Prosthesis / Hemorrhage - chemically induced / Human health sciences / Humans / Intention to Treat Analysis / Kaplan-Meier Estimate / Male / Platelet Aggregation Inhibitors / Platelet Aggregation Inhibitors - adverse effects / Platelet Aggregation Inhibitors - therapeutic use / Platelet Aggregation Inhibitors/adverse effects/therapeutic use / R16CO5Y76E (Aspirin) / Rivaroxaban - adverse effects / Rivaroxaban - therapeutic use / Rivaroxaban/adverse effects/therapeutic use / Safety / Sciences de la santé humaine / Statistical analysis / Systèmes cardiovasculaire & respiratoire / Thromboembolism / Thromboembolism - mortality / Thrombosis / Transcatheter Aortic Valve Replacement

2020

Yes Please

Hey, we have placed the reservation for you!

By the way, why not check out events that you can attend while you pick your title.

Oops! Something went wrong.

Looks like we were not able to place the reservation. Kindly try again later.

Are you sure you want to remove the book from the shelf?

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

2020

Confirm

Do you wish to request the book?

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

2020

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy

How would you like to get it?

Submit

We have requested the book for you!

Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.

Oops! Something went wrong.

Looks like we were not able to place your request. Kindly try again later.

Journal Article

A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement

Makkar, Raj R,

Giustino, Gennaro,

Zazula, Ana,

van Amsterdam, Ronald G.M,

Søndergaard, Lars,

Moreno, Raúl,

Gullestad, Lars,

Wildgoose, Peter,

Vranckx, Pascal,

Dangas, George D,

Tchétché, Didier,

Möllmann, Helge,

Guimarães, Ana H.C,

Kini, Annapoorna,

Mack, Michael,

Windecker, Stephan,

Welsh, Robert C,

Thomitzek, Karen,

Volkl, Albert A,

De Backer, Ole,

Baldus, Stephan,

von Lewinski, Dirk,

Seeger, Julia,

Tijssen, Jan G.P,

Schäfer, Ulrich,

Gilard, Martine,

Wöhrle, Jochen,

Herrmann, Howard C,

Valgimigli, Marco,

Mehran, Roxana

2020

Overview

Patients who had undergone successful TAVR were randomly assigned to receive either a rivaroxaban-based antithrombotic regimen or an antiplatelet-based antithrombotic regimen. At 17 months, the primary outcome of death or thromboembolic complications occurred more frequently with rivaroxaban.

Share this book

Add to My Shelf

Publisher

Massachusetts Medical Society

Subject

9NDF7JZ4M3 (Rivaroxaban)

/ A74586SNO7 (Clopidogrel)

/ Aged

/ Aged, 80 and over

/ Anticoagulants

/ Aspirin

/ Aspirin - adverse effects